City

Nanjing (1)

Seoul (1)

Condition

Metastatic or Recurrent Gastric Adenocarcinoma (2)

Her-2 Positive Gastric Cancer (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Asan Medical Center (1)

Liangjun Zhu M.M. (1)

Collaborator

Hoffmann-La Roche (1)

Intervention

envafolimab (1)

herceptin+xelox (1)

oxaliplatin (1)

s1 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Other (2)

Study Type

Interventional (2)

metastatic or recurrent gastric adenocarcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic or Recurrent Gastric Adenocarcinoma Trial in Nanjing (Envafolimab, Oxaliplatin, S1)

Recruiting

Metastatic or Recurrent Gastric Adenocarcinoma

Envafolimab
+2 more

Nanjing, Jiangsu, China

Jiangsu Cancer Institute & Hospital

Apr 19, 2022

Metastatic or Recurrent Gastric Adenocarcinoma, Her-2 Positive Gastric Cancer Trial in Seoul (Herceptin+XELOX)

Completed

Metastatic or Recurrent Gastric Adenocarcinoma
Her-2 Positive Gastric Cancer

Herceptin+XELOX

Seoul, Korea, Republic of

Asan Medical Center

Jan 6, 2020